Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03467191 · ClinicalTrials.gov registry record · Early Phase 1
Behavioral Alcohol Responses (BAR) Study
A Early Phase 1 study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Carnegie Mellon University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 782
- Enrollment target
- 1
- Study location
NCT03467191: Active Early Phase 1 study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Carnegie Mellon University.
NCT03467191 is a Early Phase 1 study of Alcohol Use Disorder and Alcohol Drinking that is active but no longer recruiting, run by Carnegie Mellon University. The registered enrollment target is 782 participants, above the 324-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (141% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03467191, a Early Phase 1 study of Alcohol Use Disorder and Alcohol Drinking, is active but no longer recruiting, sponsored by Carnegie Mellon University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 782 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to identify risk factors that prospectively predict alcohol problems in young adults.
Primary Outcome
Timeline Follow Back Method
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Alcohol
Study Locations (1)
Pennsylvania
- Carnegie Mellon University - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 782 participants |
| Start Date | 2018-02-13 |
| Est. Completion | 2025-10-31 |
| Phase | Early Phase 1 |
What the registry record for NCT03467191 still lists
NCT03467191 is an interventional study that assigns participants to a tested intervention. The registered 782 participants enrollment target is mid-sized for trials with a published cap, above the 324-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (141% higher).
The record links to 6 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03467191 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03467191 about?
NCT03467191 is a clinical study titled "Behavioral Alcohol Responses (BAR) Study". This study aims to identify risk factors that prospectively predict alcohol problems in young adults.
What is the current status of trial NCT03467191?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 782 participants. The study started on 2018-02-13. Estimated completion is 2025-10-31.
What conditions does trial NCT03467191 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Drinking, Alcoholism, Alcohol Intoxication, Alcohol; Harmful Use.
What interventions are being tested in trial NCT03467191?
The interventions under investigation include: Placebo (OTHER), Alcohol (DRUG).
Who is sponsoring clinical trial NCT03467191?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03467191 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03467191's enrollment target sits among peer trials
782 8th of 184 higher than 177 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impulsivity Domains and Subjective Response
RECRUITING · Early Phase 1
-
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
RECRUITING · Early Phase 1
-
Suvorexant and Alcohol
RECRUITING · Early Phase 1
-
Anxiety During Abstinence in AUD
RECRUITING · Early Phase 1
-
Diclofenac as a KMO Inhibitor
ACTIVE NOT RECRUITING · Early Phase 1
-
Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06575192 · 783 participants · Phase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
- NCT06118723 · 784 participants
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI